⚠ Evidence note: Most trends in this area rest on anecdote and mechanism; where real evidence exists it is usually for narrower claims than the trend makes.
Fecal Microbiota Transplantation (FMT)
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-09-17 — Ecosystem Nourishment for Gut Restoration After Fecal Transplantation: Four-arm RCT protocol (adults 40+) testing young-donor FMT vs. a fermented plant-rich high-fiber ‘microbiome rejuvenating diet’ vs. combination vs. control against inflammatory and biological aging markers — registered trial, no readout yet. [expert-opinion] (novelty: 3)
- 2026-09-23 — Transplantation of Elderly Human Gut Microbiota Into Pigs Reprograms Intestinal Barrier Function, Plasma Metabolome, and Gut Mucosal Transcriptomic Landscape: Pig study transplanting elderly human gut microbiota reprogrammed intestinal barrier function, plasma metabolome, and gut mucosal transcriptome — large-animal preclinical causal evidence that aged human microbiota can transmit aging-associated host phenotypes, strengthening the mechanistic rationale (but not the human efficacy case) for FMT-for-aging. [animal-model] (novelty: 3)
- 2026-08-25 — A geroprotective probiotic and its functional metabolite counteract inflammaging to extend healthspan: cross-connection with probiotic-metabolic-aging: MicroAge-style age-associated depletion of specific commensals (e.g. B. pseudocatenulatum) is the mechanistic rationale invoked by whole-community FMT trials for aging — same inflammaging framing, different delivery. (novelty: 3)
- 2026-07-29 — Aging Resilience Through Microbiota Optimization and Regulation: Planned human FMT trial concept: lyophilized capsules from young, physically active donors to be tested in older adults for muscle, cognitive, and metabolic endpoints — protocol/project description, no readout yet; extends the FMT-for-aging trend into a young-trained-donor, multi-domain resilience framing. [expert-opinion] (novelty: 3)
- 2026-09-04 — Akkermansia muciniphila and Its Bioactive Derivatives: Emerging Regulators of Healthy Aging: cross-connection with akkermansia-muciniphila: Akkermansia abundance is one of the compositional signals cited to justify microbiome-based aging interventions ranging from single-strain probiotics to whole-community FMT. (novelty: 3)
- 2026-03-17 — Gut Microbiota Resilience and Environmental Stressors: A Hidden Key to Lifespan Optimization?: Narrative review lists microbial therapeutics including FMT among interventions to bolster gut microbiota resilience against environmental stressors as a putative healthspan lever — synthesis/opinion, no new FMT trial data. [expert-opinion] (novelty: 3)
Open questions
Related
Contributing findings
Transplantation of Elderly Human Gut Microbiota Into Pigs Reprograms Intestinal Barrier Function, Plasma Metabolome, and Gut Mucosal Transcriptomic Landscape
23-sep-2026
novelty 3
per-area 3
strengthens
An intestine-centric view of neurodegeneration: How intestine-derived signals mediate the intestine-brain axis to impact Alzheimer's disease.
23-sep-2026
novelty 2
per-area 2
strengthens
Ecosystem Nourishment for Gut Restoration After Fecal Transplantation
17-sep-2026
novelty 3
per-area 3
strengthens
The Challenge of Cheap Interventions and Expensive Clinical Trials
07-sep-2026
novelty 2
per-area 2
mentions
Aging Resilience Through Microbiota Optimization and Regulation
29-jul-2026
novelty 3
per-area 3
strengthens
Microbiome remodeling during aging: Integrative multi-omics and spatiotemporal perspectives on immune and metabolic regulation.
21-jul-2026
novelty 2
per-area 2
strengthens
Gut Microbiota Resilience and Environmental Stressors: A Hidden Key to Lifespan Optimization?
17-mar-2026
novelty 3
per-area 3
strengthens